Literature DB >> 28656799

p53R2 is oncogenic in human cervical cancer.

Huang Bo1, Cai Weiyang1, Yanjie Zhang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28656799      PMCID： PMC5539814          DOI： 10.1080/15384101.2017.1337978

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  8 in total

1.  p53R2 overexpression in cervical cancer promotes AKT signaling and EMT, and is correlated with tumor progression, metastasis and poor prognosis.

Authors:  Chao Jiang; Rui Xu; Xiao-Xing Li; Yan-Yan Wang; Wen-Qian Liang; Ju-Deng Zeng; Shan-Shan Zhang; Xiao-Yi Xu; Yang Yang; Mei-Yin Zhang; Hui-Yun Wang; X F Steven Zheng
Journal:  Cell Cycle       Date:  2017-08-25       Impact factor: 4.534

Review 2.  The roles of p53R2 in cancer progression based on the new function of mutant p53 and cytoplasmic p21.

Authors:  Bahman Yousefi; Mohammad Rahmati; Yasin Ahmadi
Journal:  Life Sci       Date:  2014-01-28       Impact factor: 5.037

Review 3.  Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review.

Authors:  Stergios Boussios; Esmeralda Seraj; George Zarkavelis; Dimitrios Petrakis; Aristomenes Kollas; Aikaterini Kafantari; Abraam Assi; Konstantina Tatsi; Nicholas Pavlidis; George Pentheroudakis
Journal:  Crit Rev Oncol Hematol       Date:  2016-11-15       Impact factor: 6.312

4.  Cancer statistics, 2013.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2013-01-17       Impact factor: 508.702

Review 5.  Akt and p53R2, partners that dictate the progression and invasiveness of cancer.

Authors:  Bahman Yousefi; Nasser Samadi; Yasin Ahmadi
Journal:  DNA Repair (Amst)       Date:  2014-08-01

Review 6.  Novel regulators and molecular mechanisms of p53R2 and its disease relevance.

Authors:  E C Cho; Y Yen
Journal:  Biochimie       Date:  2016-01-19       Impact factor: 4.079

Review 7.  Structure, function, and mechanism of ribonucleotide reductases.

Authors:  Matthias Kolberg; Kari R Strand; Pål Graff; K Kristoffer Andersson
Journal:  Biochim Biophys Acta       Date:  2004-06-01

8.  Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.

Authors:  Jacques Ferlay; Isabelle Soerjomataram; Rajesh Dikshit; Sultan Eser; Colin Mathers; Marise Rebelo; Donald Maxwell Parkin; David Forman; Freddie Bray
Journal:  Int J Cancer       Date:  2014-10-09       Impact factor: 7.396
  8 in total
  2 in total

1.  DGCR8/ZFAT-AS1 Promotes CDX2 Transcription in a PRC2 Complex-Dependent Manner to Facilitate the Malignant Biological Behavior of Glioma Cells.

Authors:  Fangfang Zhang; Xuelei Ruan; Jun Ma; Xiaobai Liu; Jian Zheng; Yunhui Liu; Libo Liu; Shuyuan Shen; Lianqi Shao; Di Wang; Chunqing Yang; Heng Cai; Zhen Li; Ziyi Feng; Yixue Xue
Journal:  Mol Ther       Date:  2019-11-20       Impact factor: 11.454

Review 2.  Still no Rest for the Reductases: Ribonucleotide Reductase (RNR) Structure and Function: An Update.

Authors:  Marcus J C Long; Phillippe Ly; Yimon Aye
Journal:  Subcell Biochem       Date:  2022
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.